The Regulatory and Sourcing Reality BPC-157 is not FDA-approved for any therapeutic use
In 2009, a double-blind randomised-controlled trial (RCT) found significant reductions in duration of outbreaks, the number of ulcers and the level of pain in those on B12, 1000 g per day sublingually (form not reported), regardless of B12 level
Methylcobalamin, a form of B12, is particularly essential for synthesizing neuronal lipids, regenerating axonal nerves, and exerting neuroprotective effects, potentially improving conditions such as Alzheimer's disease, Parkinsonism, and dementia, while also serving as an approved treatment for peripheral neuropathy
Long-Term Benefits : Consistent use of B12 shot can lead to sustained energy levels, improved mental clarity, and overall better health
| Bruining, David H., editor